WAI CHUN BIOTEC Delays 2026 Annual Results, Trading Suspended from October 2

Stock News
10/02

WAI CHUN BIOTEC (00660) has announced that, due to the company and its auditor requiring additional time to complete the audit, it will be unable to publish its 2026 annual results on or before September 30, 2026, as required under Listing Rule 13.49(1).

The company is working closely with its auditor, providing all necessary information and documents to complete the audit procedures as soon as possible, but further discussions with the auditor are needed to determine the expected publication date of the annual results, and an announcement will be made in due course.

Under Listing Rule 13.50, if an issuer fails to publish periodic financial information in accordance with the Listing Rules, the Hong Kong Stock Exchange will typically require a suspension of trading in the issuer's securities, and such suspension will generally continue until the issuer publishes an announcement containing the required financial information.

In accordance with the Listing Rules, if the 2026 annual results are not published before September 30, 2026, trading in the company's shares is expected to be suspended on the Stock Exchange, effective from 9:00 a.m. on the next business day following that deadline, which is October 2, 2026.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10